Celldex Therapeutics, Inc. 4
4 · Celldex Therapeutics, Inc. · Filed Jun 16, 2017
Insider Transaction Report
Form 4
Brownlie Keith L
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2017-06-15+8,000→ 8,000 totalExercise: $2.32From: 2018-06-15Exp: 2027-06-15→ Common Stock (8,000 underlying) - Award
Common Stock, par value $0.001 per share
2017-06-15+10,000→ 10,000 total - Award
Non-Qualified Stock Option (right to buy)
2017-06-15+15,000→ 15,000 totalExercise: $2.32From: 2018-06-15Exp: 2027-06-15→ Common Stock (15,000 underlying)
Footnotes (4)
- [F1]On June 15, 2017, the Company awarded 10,000 shares of Company common stock as an annual equity grant in the form of restricted stock awards under the Celldex Therapeutics, Inc. 2008 Stock Option Plan subject to time-based forfeiture restrictions.
- [F2]Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.
- [F3]Such option vests in three equal annual installments beginning June 15, 2018.
- [F4]100% of the total amount of shares subject to the Option vests on June 15, 2018.